Stent Graft Balloon Catheter Market Analysis and Forecast by Fact.MR
The global market for stent graft balloon catheter is estimated to be around USD 1.2 billion in 2026 and has been forecast to expand at a CAGR of 7.0% to end up at USD 2.4 billion by 2036. The Stent Graft Balloon Catheter segment is led by Stent Graft Balloon Catheters, which is anticipated to account for 54.0% of the product segment in 2026, while Stent Graft Balloon Catheters is expected to remain the leading application with around 54.0% share. The market was valued at USD 1.1 billion in 2025 and is poised for steady growth driven by evolving industry dynamics and regional demand patterns.
Summary of Stent Graft Balloon Catheter Market
- Market Snapshot
- In 2025, the global Stent Graft Balloon Catheter Market was valued at approximately USD 1.1 billion.
- The market is estimated to reach USD 1.2 billion in 2026 and is projected to attain USD 2.4 billion by 2036
- The stent graft balloon catheter market is likely to expand at a CAGR of 7.0% during the forecast period.
- The market is anticipated to create an absolute dollar opportunity of USD 1.2 billion between 2026 and 2036.
- Stent Graft Balloon Catheters account for 54.0% of market share in 2026.
- China (9.5%) and India (8.8%) are the key growth markets during the forecast period
- Demand and Growth Drivers
- Growing adoption of endovascular aortic repair (EVAR) and thoracic endovascular repair (TEVAR) is increasing demand for stent graft balloon catheters used in graft deployment and post-dilation.
- Rising prevalence of aortic aneurysms and peripheral vascular disease is expanding the patient population requiring endovascular intervention.
- Catheterization and hybrid operating room infrastructure expansion in Asia Pacific is broadening access to complex endovascular procedures.
- Product and Segment View
- Stent graft balloon catheters account for 54% of the product segment in 2026, serving as essential devices for endovascular graft deployment and vessel preparation.
- Balloon expansion technology holds 51% in 2026, reflecting the standard approach for stent-graft deployment and post-dilation in endovascular procedures.
- Hospitals hold 63% of end-use demand in 2026, with vascular surgery and interventional radiology departments as the primary procedure settings.
- Geography and Competitive Outlook
- China leads at 9.5% CAGR, driven by expanding endovascular procedure volumes and vascular surgery infrastructure development.
- North America and Europe remain the largest markets with established EVAR/TEVAR procedure bases.
- Medtronic holds 28% market share through its integrated endovascular stent-graft and catheter delivery systems.
- Analyst Opinion
- The stent graft balloon catheter market is closely tied to endovascular aortic repair procedure volumes, which are growing as the technique displaces open surgical repair across a broader patient population. Device demand is procedure-linked, with each EVAR/TEVAR case requiring balloon catheters for graft deployment and molding. Growth is concentrated in Asia Pacific where vascular surgery infrastructure is scaling rapidly. The competitive advantage accrues to companies offering integrated stent-graft delivery systems where the balloon catheter is a component of a proprietary platform, creating switching costs and procedure-level lock-in. Drug-coated balloon variants represent an emerging opportunity for combining vessel preparation with anti-restenotic therapy.
Why is the Stent Graft Balloon Catheter Market Growing?
- Endovascular aortic repair adoption is expanding as the technique displaces open surgery across a broader range of aortic pathologies and patient demographics.
- Peripheral vascular disease prevalence growth is increasing interventional procedure volumes requiring balloon catheter-assisted stent-graft deployment.
- Hybrid operating room construction in emerging markets is enabling complex endovascular procedures previously limited to specialized centers.
The stent graft balloon catheter market is a direct derivative of endovascular procedure volume growth. Each EVAR, TEVAR, or peripheral stent-graft procedure requires balloon catheters for device deployment, vessel preparation, and post-dilation, creating a procedurally linked demand model.
The shift from open surgical to endovascular repair continues to expand the addressable patient population. Advances in stent-graft design, including fenestrated and branched configurations, are extending endovascular treatment to more complex anatomies, with each case requiring specialized balloon catheter support.
Segment-wise Analysis of the Stent Graft Balloon Catheter Market
- Stent graft balloon catheters lead at 54% share in 2026, serving endovascular graft deployment and post-dilation.
- Balloon expansion technology holds 51% in 2026, with inflation-based graft deployment as the standard technique.
- Sterile single-use kits account for 67% of packaging in 2026, meeting regulatory sterilization and traceability requirements.
The market is segmented by product type (stent graft balloon, semi-compliant balloon, non-compliant balloon, drug-coated balloon catheters), end use (hospitals, ambulatory surgical centers, specialty clinics, academic and research institutes), technology (balloon expansion, drug-coated balloon, hybrid stent-graft systems), and packaging (sterile single-use kits, medical pouch, bulk hospital packaging).
Which Product Segment Leads?
Stent graft balloon catheters hold 54% of the product segment in 2026. Their leadership reflects the essential role of balloon inflation in endovascular graft deployment and vessel molding. Non-compliant and semi-compliant variants serve post-dilation and vessel preparation roles, while drug-coated balloon catheters are gaining share as pharmacological therapy integration advances.
Which Technology Drives Largest Demand?
Balloon expansion technology accounts for 51% in 2026. Inflation-based stent-graft deployment remains the standard approach in EVAR and TEVAR procedures. Drug-coated balloon technology is the fastest-growing sub-segment, combining vessel preparation with localized drug delivery to reduce restenosis in peripheral applications.
Key Growth Drivers, Constraints, and Market Scope
- Endovascular procedure volume growth creates procedurally linked device demand.
- Expanding treatment indications for complex aortic anatomies increase per-case device utilization.
- High device costs and reimbursement limitations constrain adoption in price-sensitive markets.
The stent graft balloon catheter market is shaped by vascular disease epidemiology, endovascular procedure adoption, device technology development, and reimbursement frameworks.
Growth Drivers
Demand is shaped by EVAR/TEVAR procedure volume growth, expanding endovascular treatment indications, and hybrid OR infrastructure development in emerging markets. Aging population demographics increase vascular disease prevalence and procedure candidacy.
Constraints
High device costs limit adoption in emerging markets without adequate reimbursement. Procedural complexity restricts use to specialized centers with trained vascular surgeons. Regulatory approval timelines for new device designs delay market entry.
Opportunities
Drug-coated balloon catheters for peripheral applications combine mechanical and pharmacological therapy. Complex aortic repair requiring fenestrated/branched grafts increases per-case balloon utilization. Asian market infrastructure expansion creates the largest procedural volume growth opportunity.
Regional Outlook Across Key Markets
.webp "Top Country Growth Comparison Stent Graft Balloon Catheter Market Cagr (2026 2036)")
- China leads at 9.5% CAGR, driven by vascular surgery infrastructure expansion and growing aortic disease prevalence.
- India follows at 8.8% CAGR, reflecting expanding endovascular procedure capacity.
- Germany records 8.1% CAGR, supported by established vascular surgery volumes and complex case capabilities.
- USA grows at 6.7% CAGR, with mature procedure volumes and device technology advancement.
Country CAGR Table
| Country |
CAGR (%) |
| China |
9.5% |
| India |
8.8% |
| Germany |
8.1% |
| Brazil |
7.4% |
| USA |
6.7% |
| UK |
6.0% |
| Japan |
5.3% |
Regional demand reflects vascular disease prevalence, endovascular procedure adoption, hospital infrastructure maturity, and reimbursement support for advanced vascular devices.
Market Outlook in China
The China stent graft balloon catheter market is projected to grow at a CAGR of 9.5% through 2036. Demand is driven by rapid vascular surgery infrastructure expansion, increasing aortic disease prevalence, and growing adoption of EVAR/TEVAR techniques.
- Vascular surgery infrastructure expansion broadens procedure access.
- Aortic disease prevalence growth increases intervention volumes.
- Local device manufacturers are entering the market with cost-competitive offerings.
Demand Trends in India
The India stent graft balloon catheter market is projected to grow at a CAGR of 8.8% through 2036. Growth reflects expanding endovascular procedure capacity, growing tertiary hospital infrastructure, and increasing vascular disease burden.
- Endovascular capacity expansion drives procedure volume growth.
- Tertiary hospital infrastructure supports complex vascular interventions.
- Growing disease burden increases patient candidacy for intervention.
Germany Market Growth
The Germany stent graft balloon catheter market is projected to grow at a CAGR of 8.1% through 2036. Demand is supported by established vascular surgery centers, complex case expertise, and reimbursement support for advanced endovascular procedures.
- Established vascular centers support high procedure volumes.
- Complex case capabilities drive advanced device utilization.
- Reimbursement frameworks support specialty device procurement.
USA Market Outlook
The USA stent graft balloon catheter market is projected to grow at a CAGR of 6.7% through 2036. Demand is shaped by mature EVAR/TEVAR procedure volumes, advancing device technology, and expanding treatment indications for complex anatomies.
- Mature procedure volumes sustain consistent device demand.
- Technology advancement drives device iteration and upgrade cycles.
- Expanding treatment indications increase per-case device utilization.
Competitive Benchmarking and Company Positioning
- Medtronic holds 28% market share through its integrated endovascular stent-graft delivery systems spanning aortic and peripheral applications.
- Cook Medical and B. Braun compete through established vascular device portfolios and hospital distribution networks.
- Competition is shaped by stent-graft platform integration, delivery system design, physician training programs, and clinical evidence.
The competitive landscape is shaped by integration between stent-graft platforms and balloon catheter delivery systems. Medtronic leads through its Endurant and Valiant stent-graft systems, where balloon catheters are integral to the deployment mechanism. Cook Medical, B. Braun, and Terumo compete through established vascular device portfolios.
Strategic priorities include developing drug-coated balloon variants, improving catheter crossing profiles and deliverability, expanding hybrid stent-graft system capabilities, and building distribution in emerging market vascular surgery centers.
Competitive Benchmarking
| Company |
Platform Integration |
Vascular Portfolio |
Clinical Evidence |
Geographic Reach |
| Medtronic |
Full system |
Comprehensive |
Extensive |
Global |
| Cook Medical |
Moderate |
Broad |
Strong |
Global |
| B. Braun |
Moderate |
Focused |
Moderate |
Europe/Asia |
| Terumo |
Moderate |
Catheter focused |
Moderate |
Global |
| Boston Scientific |
Growing |
Broad |
Strong |
Global |
Recent Industry Developments
- Medtronic launched an updated balloon delivery system for its aortic stent-graft platform in 2025, featuring improved catheter profile for percutaneous access.
- Cook Medical expanded its peripheral stent-graft balloon catheter line in early 2026, targeting growing femoropopliteal intervention volumes.
- MicroPort received regulatory approval for its stent graft balloon catheter system in China in 2025, targeting domestic vascular surgery market growth.
Leading Companies Shaping the Stent Graft Balloon Catheter Market
-
Major Players
- Medtronic Plc
- B. Braun Melsungen AG
- Cook Medical INC
- Terumo Corporation
- Boston Scientific Corporation
-
Emerging Players
- Cordis Corporation
- MicroPort Scientific Corporation
- Jotech GmbH
- Cardionovum GmbH
- Hexacath
- Abbott Laboratories
- Meril Life Sciences Pvt. Ltd.
Sources and Research References
- Society for Vascular Surgery (SVS). Procedure volume and clinical practice data.
- European Society for Vascular Surgery (ESVS). Clinical guidelines for endovascular repair.
- Medtronic Plc. Annual reports and endovascular portfolio disclosures.
- World Health Organization (WHO). Cardiovascular and vascular disease epidemiology.
- United States Food and Drug Administration (FDA). Medical device regulatory databases.
- Primary interviews with vascular surgeons, interventional radiologists, hospital procurement managers, and device distributors.
This bibliography is provided for reader reference. The full report contains the complete reference list.
Key Questions This Report Addresses
- What is the current and projected size of the stent graft balloon catheter market?
- What CAGR is expected between 2026 and 2036?
- Which product type holds the largest share?
- Which technology drives the highest demand?
- What factors shape demand?
- Which countries show fastest growth?
- How is the competitive landscape structured?
- How does Fact.MR validate the forecast?
Stent Graft Balloon Catheter Market Definition
The stent graft balloon catheter market covers balloon-based catheter devices used in endovascular stent-graft deployment, post-dilation, and vessel preparation during aortic, peripheral, and other vascular repair procedures. The market spans device manufacturing and distribution to hospital vascular surgery and interventional radiology departments.
Stent Graft Balloon Catheter Market Inclusions
The scope covers global and regional market size and forecasts for 2026 to 2036 across product type, end use, technology, packaging, and region. It includes demand analysis based on vascular disease prevalence, EVAR/TEVAR procedure volumes, and endovascular infrastructure development.
Stent Graft Balloon Catheter Market Exclusions
The scope excludes standalone bare-metal and drug-eluting stents without balloon delivery, diagnostic catheters, non-vascular balloon devices, and open surgical graft materials not deployed endovascularly.
Stent Graft Balloon Catheter Market Research Methodology
- Primary research includes interviews with vascular surgeons, interventional radiologists, hospital procurement managers, and device distributors.
- Desk research draws on vascular disease epidemiology, procedure volume statistics, device regulatory databases, and company financial disclosures.
- Market sizing uses a demand-side model validated through procedure volume cross-checks, device utilization rates, and pricing benchmarks.
- Data validation involves reconciliation with medical device registry data and expert panel review.
